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Abstract
Background: Chronic chagasic cardiomyopathy is a debilitating and frequently fatal outcome of
human infection with the protozoan parasite, Trypanosoma cruzi. Microarray analysis of gene
expression during the T. cruzi life-cycle could be a valuable means of identifying drug and vaccine
targets based on their appropriate expression patterns, but results from previous microarray
studies in T. cruzi and related kinetoplastid parasites have suggested that the transcript abundances
of most genes in these organisms do not vary significantly between life-cycle stages.
Results: In this study, we used whole genome, oligonucleotide microarrays to globally determine
the extent to which T. cruzi regulates mRNA relative abundances over the course of its complete
life-cycle. In contrast to previous microarray studies in kinetoplastids, we observed that relative
transcript abundances for over 50% of the genes detected on the T. cruzi microarrays were
significantly regulated during the T. cruzi life-cycle. The significant regulation of 25 of these genes
was confirmed by quantitative reverse-transcriptase PCR (qRT-PCR). The T. cruzi transcriptome
also mirrored published protein expression data for several functional groups. Among the
differentially regulated genes were members of paralog clusters, nearly 10% of which showed
divergent expression patterns between cluster members.
Conclusion: Taken together, these data support the conclusion that transcript abundance is an
important level of gene expression regulation in T. cruzi. Thus, microarray analysis is a valuable
screening tool for identifying stage-regulated T. cruzi genes and metabolic pathways.
Background
Trypanosoma cruzi, the etiologic agent of Chagas disease in
humans, is a protozoan parasite which assumes four mor-
phological stages during its cycle in insect and mamma-
lian hosts. In the reduviid insect vector, T. cruzi
epimastigotes replicate extracellularly in the lumen of the
gut. As the parasite stages reach the posterior end of the
gut they attach to the wall of the rectum and convert to
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non-replicative, infective metacyclic trypomastigotes that
are released in the feces when the bug takes a blood meal.
The metacyclic trypomastigotes enter the mammalian
host when they are rubbed into the bite wound or other
open skin or mucosal surfaces and invade host cells. The
intracytoplasmic parasites convert to the replicative,
amastigote stage and undergo many rounds of division
before transforming into elongated, motile trypomastig-
ote stages which are released when the host cell ruptures.
The trypomastigotes are disseminated in the blood and
lymph where they may infect virtually any nucleated cell
or be taken up by the insect vector to complete the life
cycle. A detailed description of the T. cruzi life-cycle with
accompanying diagram can be accessed at the web site for
the Centers for Disease Control and Prevention
http:www.dpd.cdc.gov/dpdx/html/trypanosomiasisamer
ican.htm.
There are no vaccines for Chagas disease, and specific
chemotherapy for T. cruzi infection is hindered by adverse
side-effects and questionable efficacy. In order to broadly
screen for genes with relevant expression patterns, and to
learn more about the biology of T. cruzi in general, we and
others have conducted transcriptomic and proteomic
analyses of T. cruzi life-cycle stages [1-11]. Although these
analyses have highlighted potential drug and vaccine tar-
gets, they have been somewhat limited in scope, largely
non-quantitative, and rarely correlated transcript and pro-
tein abundances. The latter issue is of particular impor-
tance for T. cruzi and other kinetoplastids, due to the
generally accepted view that regulation of gene expression
in the kinetoplastids is almost entirely post-transcrip-
tional (reviewed in [12,13]). In fact, only one kineto-
plastid RNA pol II promoter has been described despite
repeated attempts in many laboratories (reviewed i [14]).
Other studies have implicated mRNA processing [15],
translational repression [16-18], polysome recruitment
[19], and codon adaptation [20] in the regulation of gene
expression in the kinetoplastids, all processes that would
be predicted to mitigate the role of mRNA abundance reg-
ulation in determining protein expression levels. Indeed,
previous microarray studies in the kinetoplastids have
revealed relatively modest numbers of genes whose tran-
script abundances are significantly regulated (reviewed in
[21]). There is, however, plentiful evidence that transcript
levels in these parasites are controlled by mRNA decay,
involving 3'-UTRs and RNA-binding proteins [19,22-28].
To determine the extent of mRNA abundance regulation
in T. cruzi globally, we performed whole-genome, DNA
microarray analysis of the four life-cycle stages of T. cruzi.
The results of these analyses were compared with existing
protein expression data for T. cruzi to determine the corre-
lation, if any, between transcript and protein relative
abundances in this human pathogen.
Results
T. cruzi displays significant stage-regulation of relative 
transcript abundances for thousands of its genes
Co-hybridization of cDNAs from each T. cruzi life-cycle
stage with a reference cDNA sample comprised of all four
life-cycle stages on oligonucleotide, whole genome micro-
arrays, revealed that over 83% of the oligonucleotides
detected transcript above background levels and were con-
sistent between dye-swap replicates in at least three life-
cycle stages (10,256/12,288). Significance Analysis of
Microarrays (SAM) [29] determined that a total of 4,992
of these transcripts exhibited statistically significant up or
down regulation in at least one of the four life-cycle stages
with a median false discovery rate (FDR) of 0.06071%
(3.03 spots) and a 90th percentile FDR of 0.40582%
(20.26 spots). Whether one includes or excludes members
of large gene families from the analysis, >50% of the genes
with detectable signals were significantly regulated during
the course of the T. cruzi life-cycle (Table 1). The signifi-
cant regulation of thousands of T. cruzi genes is visually
apparent in the heat map of significantly regulated genes
(Figure 1). Note that the significantly regulated genes
show consistency between biological replicates, particu-
larly in stages where the extent of up or down regulation
is the greatest. The expanded clusters in Figure 1 are highly
enriched in trypomastigote-upregulated trans-sialidases
(TS) and mucins.
Of the genes upregulated in two stages, 76% (1083/
1423), were co-upregulated in stages occurring in the
same host (mammalian hosts – amastigotes and trypo-
mastigotes; insect hosts – epimastigotes and metacyclic
trypomastigotes), whereas approximately 20% (282/
1423) were co-upregulated in stages with similar biologi-
cal functions. For example, genes co-upregulated in amas-
tigotes and epimastigotes (dividing stages) were enriched
in those involved in DNA repair, including proliferative
cell nuclear antigen (PCNA). Likewise, genes co-upregu-
lated in trypomastigotes and metacyclic trypomastigotes
(non-dividing, infective stages) included never in mitosis
(NIMA) related kinase and were enriched for trans-siali-
dases (TS), which are involved in invasion (reviewed in
[30]).
The validity of T. cruzi microarray data is supported by 
qRT-PCR and by comparison to existing proteomic data
The accuracy of the microarray results was confirmed by
quantitative reverse-transcriptase PCR (qRT-PCR) for a
subset of the significantly regulated genes.
For 12 out of 12 genes showing significant up or downreg-
ulation by microarray analysis in trypomastigotes, qRT-
PCR data agreed in direction of regulation (Figure 2A).
Similar agreement was seen in the case of epimastigotesBMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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(16 out of 16) and amastigotes (13 out of 14) genes (Fig-
ure 2B and 2C).
Further validation of the microarray results came from
comparison to known protein expression profiles for
selected genes. For example, proteomic analyses indicated
most TS gene expression occurs in trypomastigotes and
significantly fewer TS proteins are detected in amastigotes
and metacyclic trypomastigotes (and none detected in
epimastigotes) [8]. A similar pattern of expression was evi-
dent in the transcriptome data (Figure 3 and Additional
file 8). Gene set enrichment (GSE) analysis [31,32] of
genes >2-fold upregulated in trypomastigotes and signifi-
cantly regulated (by SAM analysis) also revealed enrich-
ment of trans-sialidases (using the gene ontology (GO)
molecular function term "exo-alpha-sialidase activity";
hypergeometric P-value of 4.1E-25; 1.8E-22 with Ben-
jamini correction for FDR). Several TS mRNAs were
detected in epimastigotes, in agreement with previous EST
analyses [33]. Interestingly, of the 12 TS genes showing 2-
fold or greater transcript upregulation in epimastigotes,
11 were also upregulated in metacyclic trypomastigote
stages (Figure 4), consistent with the possibility they are
translationally repressed in epimastigotes and subse-
quently translated in metacyclic trypomastigotes.
Other gene groups showing concordance between the
transcriptome and whole proteome analyses included
genes for ribosomal proteins (downregulated in metacy-
clics) and genes in the histidine-to-glutamate pathway
(upregulated in epimastigotes) [8] (Figure 5A and 5B and
Additional file 9). We also observed the expected upregu-
lation of mucin genes in trypomastigotes (reviewed in
[34]; confirmed by hypergeometric P-value of 1.5E-37 for
GSE) and the downregulation of flagellum-associated
genes in amastigotes (which lack flagella; hypergeometric
P-value of .00153 for GSE) (Figure 5C and 5D and Addi-
tional file 10).
The T. cruzi microarray data provide expanded coverage 
of important functional groups
The concordance between the presently reported tran-
scriptomic data and published proteomic data suggests
that the mRNA relative abundances observed here will be
useful indicators of the protein expression levels of genes
for which protein expression data has not been reported,
including many genes annotated as 'hypothetical.' Cur-
rent proteomic methods often fail to detect or quantify
proteins that are expressed at low levels, (e.g. protein
kinases and phosphatases; reviewed in [35]) or proteins
that have physical properties making them less amenable
to proteomic analyses, (e.g. membrane proteins; reviewed
in [36]). For example, this transcriptomic analysis
detected 30 protein phosphatases and 128 protein
kinases, which were significantly regulated at the tran-
script level (Additional files 1 and 2), and few of which
have published protein expression data. Likewise, our
transcriptome analysis detected 166 significantly regu-
lated genes annotated as 'integral-to-membrane' (Addi-
tional file 3).
Members of many T. cruzi paralog clusters exhibit 
significant stage-regulated divergence in mRNA relative 
abundance patterns
Kinetoplastids appear to maintain multiple copies of
genes for which high level expression is required [37,38].
Hence we expected that genes in paralog clusters would
have similar expression patterns and were surprised to
find that over 10% (105/1023) of the T. cruzi paralog
groups containing 3–15 members had divergent mRNA
Table 1: With or without the contribution of large gene family members, greater than 50% of the Trypanosoma cruzi genes detected on 
whole-genome, oligonucleotide microarrays were significantly stage-regulated at the RNA level.
# spots (percent of total) # genes (percent of total)
all SIG1 4273 (51.6) 6708 (52.2)
NON-SIG2 4000 (48.4) 6141 (47.8)
Total 8273 (100) 12849 (100)
large gene families3 SIG 739 (50.1) 1010 (51.5)
NON-SIG 735 (49.9) 950 (48.5)
Total 1474 (100) 1960 (100)
minus large gene families SIG 3534 (52.0) 5698 (52.3)
NON-SIG 3265 (48.0) 5191 (47.7)
Total 6799 (100) 10889 (100)
The oligonucleotide sequences were aligned against the T. cruzi genome by BLAST analysis [58]. Oligonucleotides showing 80% or greater identity 
with more than three T. cruzi gene ID's were not counted.
1Significantly stage-regulated as determined by SAM analysis (FDR = 0.4%).
2Non-significantly stage-regulated as determined by SAM analysis (FDR = 0.4%).
3Oligonucleotides mapping to members of large gene families (number of members > 30).BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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Heat map of genes significantly regulated during the life-cycle of Trypanosoma cruzi Figure 1
Heat map of genes significantly regulated during the life-cycle of Trypanosoma cruzi. Ratios are log2 (stage/refer-
ence), thus yellow bars represent upregulation and blue bars represent downregulation. Two trypomastigote upregulated clus-
ters are expanded. The spots annotated as 'not mappable to annotated ORF' were designed from earlier versions of the T. cruzi 
genome sequence and subsequently designated as 'obsolete' by TIGR. These spots no longer mapped within an annotated ORF 
in the final version of the genome sequence, e.g. they were in intergenic regions (such as untranslated regions) and/or were 
antisense (would hybridize with first strand cDNA from transcripts from the non-coding strand).BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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relative abundance patterns (Figure 6). One of these
groups was the amastins, a paralog group previously
reported to be largely amastigote-specific [37] but herein
shown to include members with significant stage-specific
upregulation in insect stages. The divergent expression
patterns of the T. cruzi amastins were confirmed by qRT-
PCR (Figure 6) and are also supported by the detection of
amastin in the metacyclic trypomastigote proteome [8].
In addition to increasing transcript abundance, another
presumed function of gene duplication is to allow for the
development of new protein functions [38]. Such neo-
functionalization may have occurred in the T. cruzi 60S
ribosomal L18 protein paralog group (Figure 6).
Tc00.1047053503395.40, which was upregulated in try-
pomastigotes, has a 130 amino acid N-terminal extension
not found in any other publicly-available 60S ribosomal
L18 sequence, suggesting the possibility that this paralog
has a novel function in T. cruzi trypomastigotes.
Discussion
Transcriptomic analyses have not been as aggressively
pursued in kinetoplastid organisms as they have been in
other protozoan parasites, such as Plasmodium. This is
likely due to the view that the predominantly post-tran-
scriptional nature of gene expression regulation in kineto-
qRT-PCR confirmation of relative transcript abundances for microarray-identified, significantly regulated genes Figure 2
qRT-PCR confirmation of relative transcript abundances for microarray-identified, significantly regulated 
genes. Mean log2 ratios (stage/reference) for selected genes in selected stages determined by qRT-PCR and microarray analy-
ses. Gene ID's are official gene symbols (prefix Tc00.1047053 is truncated) assigned to annotated genes in the reference CL 
Brener T. cruzi genome. Error bars are standard deviations for three biological replicates for both the microarray and qRT-PCR 
data. The qRT-PCR and microarray standard deviations reflect biological, not technical variation. A) trypomastigotes B) epi-
mastigotes C) amastigotes.BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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plastids makes microarray studies in these organisms
generally less informative than microarray studies in
organisms for which transcription initiation plays a larger
role in gene expression regulation. In support of this, the
ranges of observed mRNA ratios between life-cycle stages
in kinetoplastid organisms have been relatively narrow
compared to the ranges observed in organisms with
canonical RNA pol II promoters. For example, 1,000-fold
induction in relative transcript abundance for CD70 was
observed in a microarray study comparing Human T-lym-
photropic virus type 1 (HTLV-1) carrying T-cell lines ver-
sus HTLV-1-negative T-cell lines [41], whereas in
kinetoplastid microarray studies, fold inductions above
~8-fold are rarely observed [3,42-46].
Further contributing to the debate over the utility of
microarray studies in kinetoplastids has been the general
observation that relatively few genes have exhibited signif-
icant stage regulation of mRNA relative abundances in
previous microarray studies. For instance, Diehl et al.,
using arrays of 21,024 PCR-amplified genome shot-gun
library inserts from T. brucei to compare relative transcript
abundances between in vitro cultured human, long slen-
der forms and procyclic parasites, observed that, although
75% of the array elements detected transcripts, only 2%
displayed significant differences between the two life-
cycle stages [39]. The observation that only 2% of the
detected transcripts differed significantly in relative abun-
dance between two very different life-cycle stages sup-
ported the concept that transcript abundances in T. brucei
are largely constitutive, especially considering the two life-
cycle stages were compared directly on the microarrays.
This picture of predominantly constitutive genome
expression at the level of transcript abundance in kineto-
plastids was reinforced manifold by subsequent studies in
T. brucei [40] and Leishmania spp. (reviewed in [41]).
In light of the findings from T. brucei and Leishmania spp.
microarray studies as well as findings from our previous,
limited microarray study in T. cruzi [3], we sought to
determine if transcript levels are globally variable between
life-cycle stages of T. cruzi using whole-genome oligonu-
cleotide microarrays. When cDNAs from each life-cycle
stage were co-hybridized with a reference cDNA sample
comprised of all four life-cycle stages on oligonucleotide,
whole genome microarrays, we observed that the relative
transcript abundances for over 50% of the genes detected
on the arrays were significantly regulated between the life-
cycle stages.
The microarray data for selected genes were validated by
qRT-PCR. There was generally good agreement between
the two platforms in terms of direction of regulation,
however there were some quantitative differences, espe-
cially in terms of the extent of up or downregulation esti-
mated by these two techniques. These quantitative
differences likely were the result of sequence-specific
effects and differences in dynamic range for the two plat-
forms [49,50]. In addition, the RNA samples used for
qRT-PCR were not the identical samples used for the
microarrays.
Recent improvements in microarray design, such as the
use of oligonucleotide probes designed for more uniform
hybridization kinetics and with lower likelihood of cross-
hybridization than amplicon-derived probes and the use
of microarrays with greater genome coverage could in part
account for why our study identified a higher percentage
of significantly stage-regulated genes than previous micro-
array studies in other kinetoplastids [1-4,39,42]. How-
ever, even a recent study by Rochette et al. that used
Leishmania whole genome oligonucleotide microarrays to
directly compare amastigotes and procyclics reported that
only 7% of the genes in Leishmania infantum and 9.3% of
the genes in L. major were developmentally regulated [43].
It is also possible that the use of different statistical meth-
ods for analysis of microarray data my yield widely differ-
ent estimates of the frequency of regulated genes.
However, using less rigorous statistical criteria for deter-
mining significance, such as fold-change, results in higher
false discovery rates [29] and thus would be predicted to
overestimate the number of significantly regulated genes.
Microarray-identified, significantly regulated Trypanosoma  cruzi trans-sialidase (TS) genes Figure 3
Microarray-identified, significantly regulated 
Trypanosoma cruzi trans-sialidase (TS) genes. Shown 
are mean microarray log2 ratios (stage/reference) for TS sig-
nificantly regulated in Trypanosoma cruzi amastigotes (AMA), 
trypomastigotes (TRYP), epimastigotes (EPI), and metacyclic 
trypomastigotes (META). The y-axis scale is provided as a 
reference for gene order for the genes in Additional file 8, 
which shows the mean log2 ratios for three biological repli-
cates for each life cycle stage and their standard deviations. 
The genes are in the same order in each panel.BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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Our reanalysis of the Papadopoulou data from L. infantum
using our statistical methods found 715 genes (7% of the
genes fulfilling our criteria for detection) to be signifi-
cantly regulated between amastigotes and promastigotes
with an FDR of 1.55% (an FDR nearly 4 times greater than
what we report for T. cruzi). Thus, different statistical anal-
ysis methods cannot account for the differential estimates
of the frequency of regulated genes in Leishmania and T.
cruzi.
By incorporating all four life cycle stages of T. cruzi in our
analysis, in contrast to the 2 stage comparisons done with
other kinetoplastids (e.g. procyclic to amastigote [43] or
procyclic to bloodstream forms [39]) we have increased
the possibility of identifying a greater number of genes
regulated in expression in at least one of the 4 life cycle
stages. However, the contribution of increased number of
stages studied to the overall number of significantly regu-
lated genes was greatly mitigated by the fact that we used
a reference design in which each life-cycle stage was com-
pared to a mixture of all four life-cycle stages. This design
minimized the number of microarrays required to com-
pare the four life-cycle stages (each stage vs. reference = 24
hybridizations in the present study, each stage vs. each
other stage = 36 hybridizations for equivalent replica-
tion), and also simplified the analysis, but had the disad-
vantage of buffering the ratios observed. By contrast,
previous microarray studies in the kinetoplastids involved
directly comparing one life-cycle stage with another on
the microarrays, an experimental design which should
maximize the number of significant ratios. Thus our esti-
mate that >50% of genes in T. cruzi have significantly
stage-regulated transcript levels is much more likely to be
an underestimate than an overestimate.
The number of significantly stage-regulated transcripts
reported here for T. cruzi is also likely to be underesti-
mated because >2,000 of the oligonucleotide probes
detected transcripts in two or fewer stages and were
removed from further analysis for statistical reasons (sig-
nificance determination for such genes would have been
dubious, because SAM analysis of four groups (life-cycle
stages) was unreliable for genes present in less than three
groups). Also, almost certainly some of the genes that we
reported as non-significantly regulated are significantly
regulated in transitional stages of the life-cycle. For
instance, Saxena et al., using microarrays of ~8300 PCR-
amplified genome survey sequencing (GSS) clone inserts,
identified 344 protein coding genes significantly regu-
lated during axenic promastigote-to-amastigote differenti-
ation in Leishmania donovani [52]. Of these, 136 genes,
nearly 40% of the total number of differentially regulated
genes identified in the study, displayed transient up or
downregulation that would have been missed by only
comparing fully differentiated parasites. Thus our analysis
of only fully differentiated stages likely underestimated
the percentage of genes we found significantly regulated at
the transcript level during the T. cruzi life cycle, suggesting
that time course studies looking at transitional stages in T.
cruzi would be fruitful.
The disparity in the degree of transcript abundance regu-
lation between T. cruzi and the other sequenced kineto-
plastids suggests there may be differences in the number
and kind of RNA binding proteins in their genomes,
because almost all regulation of mRNA abundance in
these organisms is at the level of mRNA stability. How-
ever, the genomes of T. cruzi, T. brucei, and L. major all
have remarkably similar complements of RNA binding
proteins (reviewed in [44]). Of the 77 proteins with RNA
Recognition Motifs (RRMs) in T. cruzi, T. brucei, and L.
major, only two were unique to T. cruzi, RBP4
(Tc00.1047053508901.20) and DRBD8 (Tc00.1047
053503709.10, Tc00.1047053509581.50), both of which
were upregulated in metacyclic trypomastigotes.
Present knowledge of the kinetoplastids does not elicit an
obvious biological explanation for why gene expression
regulation in T. cruzi might be so different from its closest
relatives. Perhaps the most striking difference between T.
cruzi and T. brucei and L. major is that only T. cruzi has
both intracellular and extracellular life-cycle stages in the
mammalian host. Amastigotes must replicate intracellu-
Microarray-identified, epimastigote upregulated Trypanosoma  cruzi trans-sialidase (TS) genes Figure 4
Microarray-identified, epimastigote upregulated 
Trypanosoma cruzi trans-sialidase (TS) genes. Mean 
microarray log2 ratios (stage/reference) in amastigotes 
(AMA), trypomastigotes (TRYP), epimastigotes (EPI), and 
metacyclic trypomastigotes (META) for significantly regulated 
TS that were at least two-fold upregulated in epimastigotes. 
Gene ID's are official gene symbols (prefix Tc00.1047053 is 
truncated) assigned to annotated genes in the reference CL 
Brener T. cruzi genome. Error bars are standard deviations 
for three biological replicates and reflect biological, not tech-
nical variation.BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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larly and, although sequestered from the actions of anti-
bodies and complement, are subjected to attack by CD8+
cytotoxic T lymphocytes (CTL) [45] and to the effects of
host cytokines [46] and antimicrobials, including reactive
oxygen species and nitric oxide [47]. Trypomastigotes are
extracellular and thus must evade host defenses including
complement, antibodies, and phagocytes. An enhanced
capacity for regulating transcript abundances may have
provided T. cruzi with the agility necessary to rapidly shift
between such different environments.
Transcript relative abundances for selected functional groups agree with published protein expression data Figure 5
Transcript relative abundances for selected functional groups agree with published protein expression data. 
Shown are mean transcript log2 ratios (stage/reference) from T. cruzi oligonucleotide microarray analyses for A) ribosomal pro-
tein genes in metacyclic trypomastigotes, B) genes in the histidine-to-glutamate pathway in epimastigotes, C) mucin genes in 
trypomastigotes, and D) flagellum-associated genes in amastigotes. The ribosomal genes were selected based on their having 
the term 'ribosomal' in their annotation and their having either proteome or transcriptome data associated with them. Gene 
ID's in panels B and D are official gene symbols (prefix Tc00.1047053 is truncated) assigned to annotated genes in the refer-
ence CL Brener T. cruzi genome. In panels A and C the y-axis scale is provided as a reference for gene order for the genes in 
Additional files 9 and 10, respectively, which show the mean microarray ratios for three biological replicates for each life cycle 
stage and their standard deviations. Error bars in panels A, B, and D are standard deviations for three biological replicates and 
reflect biological, not technical variation.BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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Duplicate genes in Trypanosoma cruzi show divergent expression patterns Figure 6
Duplicate genes in Trypanosoma cruzi show divergent expression patterns. Microarray expression data for paralog 
groups containing 3–15 members were compared to identify groups showing divergent expression between duplicate genes. 
Shown are selected groups with representative divergent expression patterns. Gene ID's are official gene symbols (prefix 
Tc00.1047053 is truncated) assigned to annotated genes in the reference CL Brener T. cruzi genome. Expression data for the 
amastins were confirmed by qRT-PCR (top right panel). Error bars are standard deviations for three biological replicates for 
both the microarray and qRT-PCR data. The qRT-PCR and microarray standard deviations reflect biological, not technical var-
iation.BMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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The finding that T. cruzi divergently regulates mRNA rela-
tive abundances for members of paralog clusters was
unexpected, given the post-transcriptional mode of gene
expression regulation in this parasite. Divergent expres-
sion of duplicate genes is believed to occur by the accumu-
lation of mutations in non-coding cis  regulatory
sequences, such as promoters [48]. Since kinetoplastids
appear to be largely devoid of canonical promoters, it will
be interesting to study the 3' untranslated regions of para-
logs with divergent expression patterns to identify the
sequences responsible for the differential mRNA abun-
dances.
The differentially regulated T. cruzi duplicate genes identi-
fied here will be useful to study the retention and neo-
functionalization of duplicate genes in an ancient
eukaryote lacking transcriptional control of gene expres-
sion. In such an environment, the contributions of mRNA
stability control and sub-cellular localization to the evolu-
tion of new genes can be studied in isolation from the
effects of transcriptional control. Gene knockout studies
are currently underway to determine if the array-identi-
fied, divergently-expressed paralogs, such as the trypo-
mastigote upregulated 60S ribosomal L18 protein, have
novel functions.
Conclusion
T. cruzi displays stage-regulated control of mRNA abun-
dances for a significant proportion of its genes despite the
fact that regulation of gene expression in the kineto-
plastids is primarily post-transcriptional and despite the
fact that previous genomic studies of the kinetoplastids
have found that only a low proportion of their genomes
are stage-regulated. Moreover, T. cruzi oligonucleotide
microarray measurements largely agree with known pro-
tein expression data for key functional groups. Taken
together, T. cruzi oligonucleotide microarray analysis is a
useful screening tool to determine stage-regulated gene
expression in this human pathogen.
Methods
Parasites
Brazil strain T. cruzi trypomastigotes were grown in mon-
olayers of Vero cells (ATCC no. CCL-81) in RPMI supple-
mented with 5% horse serum as previously described
[49]. Emergent trypomastigotes were harvested daily and
examined by light microscopy to determine the percent-
ages of amastigotes and trypomastigotes. Only prepara-
tions containing > 95% trypomastigotes were used in the
subsequent studies. Amastigotes were prepared from
axenically-induced trypomastigotes as described previ-
ously [50]. Briefly, emergent trypomastigote samples were
centrifuged at 3,000 × g for 15 m at room temperature,
brought to density of 5 × 106/ml in Protein-Free Hybrid-
oma Medium (PFHM-II, Gibco, Bethesda, MD) at pH 5.0,
and incubated at 37°C until greater than 95% of the par-
asites were fully converted to the amastigote stage as deter-
mined by microscopic examination. T. cruzi epimastigotes
were grown in Liver Infusion Tryptose media (LIT) as pre-
viously described [51]. Cultures were harvested during
mid-log phase by centrifugation at 3,000 × g for 10 m at
room temperature. Metacyclic trypomastigotes were
obtained from epimastigotes by axenic induction as previ-
ously described [52]. Briefly, log phase epimastigote cul-
tures were centrifuged at 3,000 × g for 15 m at room
temperature, brought to a density of 5 × 106/ml in Com-
plete Grace's Insect Medium (Sigma no. G8142, Sigma, St.
Louis, MO) supplemented with 10% fetal bovine serum,
pH 6.6, and incubated at 29°C for 10–14 d. The percent-
ages of metacyclics were determined by microscopic
examination of parasites stained with Dif-Quick (Baxter
Diagnostics, McGaw Park, IL).
Preparation of labeled cDNAs
Total RNA was isolated from parasites with the High Pure
Total RNA Isolation Kit (Roche) per the manufacturer's
instructions, including on-column DNase I digestion.
Labeled first strand cDNA was synthesized from the total
RNA samples using Superscript™ II reverse transcriptase
(Life Technologies, Grand Island, NY) as previously
described [3]. Briefly, 10 μg RNA were combined with 2
μg oligo-d(T) (Life Technologies), brought to 10 μl with
water, denatured at 70°C for 10 m, and cooled on ice.
Final 30 ul reactions were assembled with final concentra-
tions of 1× First Strand Buffer (Life Technologies), 10 mM
DTT (Life Technologies), 0.5 mM dATP, dCTP, and dGTP
(Amersham Pharmacia Biotech, Piscataway, NJ), 0.1 mM
dTTP (Amersham Pharmacia Biotech), 0.1 mM Cy3- or
Cy5-dUTP (Amersham Pharmacia Biotech), and 13.3 U/
μl Superscript II reverse transcriptase (Life Technologies).
The reaction mixtures were incubated at 42°C for 2 h and
stopped with the addition of 1.5 μL 20 mM EDTA. To
degrade the RNA template, 1.5 μL 500 mM NaOH were
added and the reactions were heated at 70°C for 10 m.
The reactions were neutralized by adding 1.5 μL 500 mM
HCl, and unincorporated fluorescent nucleotides were
removed using GFX columns per the manufacturer's
instructions (Amersham Pharmacia Biotech). The purified
products were eluted using 50 μL TE, pH 8.0, and the
labeled cDNA was completely dried in a SpeedVac (Savant
Instruments, Holbrook, NY, USA) and resuspended in 10
μL water.
Microarrays
The T. cruzi microarrays were obtained from the Pathogen
Functional Genomics Resource Center (PFGRC). The
microarray description is available at http://pfgrc.tigr.org.
The 12,288 unique array oligonucleotides were sense-
strand 70-mers designed against open reading frames in
the annotated CL Brener reference genome sequence andBMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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were printed in duplicate. The microarrays contained an
additional 500 control oligonucleotides designed from
Arabidopsis sequences, also printed in duplicate.
To assure accuracy in the spot-to-gene annotation, the
sequences of the oligonucleotides used on the TIGR T.
cruzi microarrays were remapped onto the T. cruzi genome
and assigned to genes. The mapping was complicated by
the fact that T. cruzi is diploid and the CL-Brener strain
used for genome sequencing is a hybrid strain [53]. Thus,
the two alleles for genes in the T. cruzi genome frequently
differ by 1–2% in their coding sequences [54], and the
terms 'allele' and 'gene' are conflated when describing the
T. cruzi genome. Moreover, complete chromosomes were
never assembled for the T. cruzi genome [54], and trip-
loidy for some loci has been confirmed [55]. As a result,
the total number of 'genes' identified by the oligonucle-
otides on the microarrays was greater than the number of
unique oligonucleotides. Thus, oligonucleotides mapping
with greater than 80% homology to three or fewer 'genes'
were used in the subsequent analyses, and oligonucle-
otides that mapped to more than three genes were not
included in the enumeration of significantly regulated
genes. Additional file 4 shows the results of our remap-
ping of the oligonucleotides to the T. cruzi annotated
genome, the original TIGR mapping, and the results of the
cross-hybridization prediction. Additional file 5 shows
the representation of large gene families (cluster designa-
tions per [54]) on the microarrays. The mucin associated
surface protein (MASP) family in particular was poorly
represented on the microarrays.
Microarray prehybridization
The microarrays were prehybridized immediately preced-
ing hybridization as described on the PFGRC website.
Briefly, arrays are incubated in prehybridization solution
(4× SSC, 40% formamide, 0.1% SDS, 0.5% BSA, and 25
mM Tris-HCl, pH 8.0) at 42°C for 1 h. Slides are then
washed at room temperature in 0.2% SDS, followed by 3
washes with water, and dried by centrifugation.
Microarray hybridization
Six hybridizations were performed for each life-cycle
stage. The hybridizations consisted of three dye-swap
experiments from three independent samples (biological
replicates). In each case, the experimental sample was
from a single life-cycle stage and the control sample was
an equal mixture of all four life-cycle stages. Hybridiza-
tions were performed as previously described [3]. Briefly,
equal volumes of control and experimental labeled
cDNAs were combined with mouse CoT1-DNA (Life
Technologies), poly(A)-DNA (Amersham Pharmacia Bio-
tech), and hybridization buffer to yield final concentra-
tions of 4× SSC, 40% formamide, 0.1% SDS, 0.5 μg/μl
CoT1-DNA, 0.5 μg/μl poly(A)-DNA, and 25 mM Tris-Cl,
pH 8.0). Samples were heat denatured at 95°C for 3 m,
centrifuged at 12,000 × g at room temperature for 1 m,
applied to the prehybridized array in a MAUI mixer cham-
ber (BioMicro Systems, Inc., Salt Lake City, Utah), placed
in a MAUI hybridization apparatus and hybridized at
42°C for 16–20 h with constant mixing. Following
hybridization, the array, with attached mixer, was
removed from the MAUI apparatus, the mixer was
removed from the array, and the array was washed once
for 2 m at room temperature in 300 ml PBS with 0.05%
SDS, followed by 3 washes for 2 m each at room temper-
ature in 300 ml PBS, and one wash for 1 m at room tem-
perature in 300 ml 0.2× PBS. The slide was then dried by
centrifugation.
Scanning and data analysis
Immediately following hybridization and washing, arrays
were scanned on a ScanArray 4000 (GSI Lumonics, Wilm-
ington, MA) at the Integrated Biotech Laboratories at the
University of Georgia. Microarrays were scanned at multi-
ple laser and photomultiplier tube (PMT) settings in each
channel to obtain Tagged Image File Format (TIFF) images
of matching sensitivity in the two channels. Microarray
scans were quantified using The Institute for Genomic
Research (TIGR) SpotFinder module of TM4 http://
www.tm4.org. Individual sub-grids within each scan-spe-
cific grid were aligned manually. Background correction
was used to flag spots with signal intensities less than local
background intensity plus one standard deviation. The
Otsu algorithm [56] was used to identify spots. The signal
intensity files generated in SpotFinder were imported into
the TIGR Microarray Data Analysis System (MIDAS) mod-
ule of TM4 http://www.tm4.org using default parameters:
e.g. MIDAS filtered spots with signal intensity in either
channel less than 1, spots with signal intensities less than
2 × local background in either channel, and spots with
integrated signal intensities less than 10,000. Since spots
typically contained approximately 100 pixels, integrated
intensities of 10,000 corresponded to mean signal inten-
sities of 100. Normalization was performed by locally
weighted least squares regression (LOWESS) within each
sub-grid using the default smoothing parameter of 0.33.
Within-slide replicate spots analysis was used to convert
the signal intensities of one replicate spot in a pair of rep-
licate spots to the geometric mean of it and its replicate
and to set the signal intensities for the other spot to zero,
thus compressing the data. The within-slide replicate
spots analysis also had the effect of setting the signal
intensities to zero for both spots in a replicate pair to zero
if the signal intensity in either channel for either spot was
zero. The normalized signal intensity files thus generated
in MIDAS were paired by dye-swap and checked for dye-
swap consistency, again using the default parameters.
Spots with greater than 2 standard deviations difference in
log2 ratios between dye-swap replicates were assigned
zero intensities. Spots that were within threshold consist-
ency were averaged (geometric mean). Thus, each set ofBMC Genomics 2009, 10:370 http://www.biomedcentral.com/1471-2164/10/370
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two input dye-swap files resulted in one output file. The
above described operations, including setting minimum
intensity cut-offs, setting signal intensities to zero for
spots with signal intensities not significantly above back-
ground, averaging of within-slide replicate spots, and set-
ting signal intensities to zero for spots with significant dye
bias were standard data manipulations for array data QC
and the utilization of technical replication (replicate spots
and dye-swap hybridizations) to eliminate the influence
of low-quality spots and/or dye bias from the downstream
data analyses [57], thus leaving only biological variation
to be evaluated, which was the intent of this study. Exam-
ple data analysis reports for the MIDAS analyses are in
Additional file 6. These analyses generated 12 result files,
one from each biological replicate for each of the four life-
cycle stages. Each row in the final result files corresponded
to eight independent measurements (2 channels × 2 rep-
licate spots × 2 dye-swap hybridizations). Using the TIGR
MultiExperiment Viewer (MeV) software the result files
were filtered to remove genes with zero intensity in more
than 3 result files (percentage cut-off of 75%), leaving
10,256 spots. The genes and experiments were median
centered and normalized using the default method for
this software. To find spots with significant, repeatable,
between-stage variation we analyzed the result files by
multi-class SAM for 4 groups (amastigotes, trypomastig-
otes, epimastigotes, metacyclic trypomastigotes – 3 files
each). The settings for the SAM analysis were: number of
permutations = 1,000 (10 times the default value), select
S0 using Tusher et al. method [29] (default), calculate q
values? = yes (not default – slow), imputation engine = K
nearest neighbors (default), number of neighbors = 10
(default), and construct hierarchical trees? = yes (not
default). Significant spots were selected with a median
false discovery rate (FDR) of 0.06071% and a 90th per-
centile FDR of 0.40582%. The microarray data were
deposited in the Gene Expression Omnibus http://
www.ncbi.nlm.nih.gov/geo/ under the accession
GSE14641.
qRT-PCR
Genes from functional groups of interest were selected for
qRT-PCR analysis in a given life-cycle stage based on the
gene being significantly regulated in the microarray anal-
ysis, as determined by SAM.
Total RNA was prepared from 3 independent samples
from each life-cycle stage as described above. RNA sam-
ples were treated with DNase I (Promega) at a final con-
centration of 1 U/μg RNA at 37°C for 45 m. RNA was
purified from the DNase digestions using RNeasy RNA
purification columns (Qiagen). First strand cDNA reac-
tions from 5 μg total RNA were primed with a mixture of
oligo d(T) and a cDNA primer (Tc-18S cDNA:
AAGAAATATCGGTGAACTTTCG) specific to the 3' end of
T. cruzi 18S rRNA. Briefly, 0.5 μg oligo d(T)V and 5
pmoles T. cruzi 18S rRNA primer were added to the RNA
samples and the primer/template mixtures were dena-
tured at 65°C for 5 m. The samples were cooled to 42°C
and final 20 μl reactions were assembled containing 1×
first strand buffer, 10 mM DTT, 0.5 mM dNTP, 40 U RNa-
sin, and 200 U SuperScript II reverse transcriptase. The
cDNA reactions were incubated at 42°C for 1.5 h. For
each RNA sample, duplicate control cDNA reactions were
prepared in which the reverse transcriptase was omitted.
Following first strand synthesis, the reactions were heat
inactivated at 70°C for 10 m, then treated with 2 U RNase
H (Invitrogen) at 37°C for 45 m.
Quantifications of selected T. cruzi genes were performed
for stage and reference cDNA samples in duplicate on an
iCyler (Bio-Rad Laboratories, Hercules, CA) with an iQ5
Multicolor Real-Time PCR Detection System (Bio-Rad).
The primer sequences used in the qRT-PCR analyses are
available in Additional file 7. Reactions were prepared
containing 5 pmoles forward and reverse primers, 1× iQ
SYBR® Green Supermix (Bio-Rad), and 2 μl template DNA.
Standard curves were prepared for each run using known
quantities of T. cruzi genomic DNA (ten-fold dilutions
beginning at 15 ng/μl) and primers for the gene being
quantified. The raw quantifications were calculated using
the iQ5 Optical Detection System software and normal-
ized to the 18S rRNA values for each sample. The final
stage/reference ratios were the averages, for each gene, of
the 9 possible normalized stage/reference comparisons (3
stage samples × 3 reference samples).
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